Updated on: July 01, 2021 9:40 IST

Govt expert panel says no to Covovax trials on children

An expert panel of the country's central drug authority on Wednesday recommended against granting permission to the Serum Institute of India (SII) to conduct the phase 2/3 trial of COVID-19 vaccine Covovax on children aged two to 17 years, sources said.